Skip to content

AccuBoost® Non-Invasive Radiotherapy

New Options For Treatment of Early Stage Breast Cancer

For most women with early stage breast cancer, localized surgical removal of the cancer (lumpectomy) followed by radiation therapy provides long term cancer treatment that is as good as removal of the entire breast (mastectomy), with fewer side effects and complications, and much better cosmetic results. This approach is referred to as Breast Conservation Therapy.

There are two well established radiation therapy options that show excellent clinical results. The first is External Beam Radiation Therapy followed by a "Boost" of localized radiation. The second is a technique called Accelerated Partial Breast Irradiation (APBI).

With External Beam Radiation Therapy, 3 to 6 weeks of daily sessions of radiation are delivered to the whole breast, followed by a higher "boost dose" of radiation delivered to the margin of tissue that originally surrounded the cancer, where cancer would be most likely to come back.

With Accelerated Partial Breast Irradiation (APBI), radiation is delivered over a period of 5 to 10 days only to the tissue surrounding the lumpectomy site. This approach may be well suited to active working women or women at a long distance from a treatment center.

Patients and their physicians can discuss the benefits and risks of each of these options, and together agree on the approach that is best suited for each person.

Breast-4WayFor either of these two approaches, New Mexico Cancer Center offers AccuBoost®, the latest innovation in breast radiotherapy. AccuBoost® uses real-time image guidance that allows your radiation oncologist to precisely target the "Boost" or the "APBI" radiation dose to the lumpectomy cavity margin. The AccuBoost® process limits unintentional exposure to otherwise healthy tissue and minimizes radiation-related side effects.

The Benefits of AccuBoost®

Regardless of the treatment approach you elect, the following benefits are typical of patients treated with this technology:

  • Accurate targeting of the dose
  • Non-invasive radiation delivery in a simple outpatient procedure
  • Low skin dose and skin complications
  • Low toxicity and excellent cosmetic results
  • Radiation is delivered parallel to the chest wall sparing unintentional exposure to the heart and lungs
  • Conformal radiation field matches the target size, shape, and location
  • Uniform and homogeneous radiation field
  • Excellent reliability and reproducibility in patient positioning and process control
  • Less exposure to healthy tissue allows for better cosmetic outcomes

Additional Information for Patients

AccuBoost® Website

Your Strongest Ally to Conquer Cancer


Scroll To Top